NPI: 1003883125 · MIAMI, FL 33136 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/07/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/07/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 47,408 | $6.16M |
| 2019 | 60,615 | $9.77M |
| 2020 | 60,786 | $9.70M |
| 2021 | 49,166 | $3.98M |
| 2022 | 39,524 | $5.07M |
| 2023 | 21,326 | $1.82M |
| 2024 | 6,351 | $602K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 94,660 | 5,739 | $13.00M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 81,314 | 3,774 | $10.16M |
| J1270 | Injection, doxercalciferol, 1 mcg | 48,342 | 2,992 | $5.78M |
| A4657 | Syringe, with or without needle, each | 11,386 | 4,183 | $1.76M |
| J1756 | Injection, iron sucrose, 1 mg | 15,739 | 2,838 | $1.67M |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 5,450 | 926 | $957K |
| 85041 | 4,330 | 2,841 | $568K | |
| 85048 | 4,300 | 2,814 | $559K | |
| 82728 | 3,853 | 2,571 | $543K | |
| 83540 | 4,160 | 2,764 | $542K | |
| 83550 | 4,028 | 2,678 | $530K | |
| 83970 | 3,393 | 2,167 | $477K | |
| A4913 | Miscellaneous dialysis supplies, not otherwise specified | 1,770 | 890 | $293K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,425 | 773 | $152K |
| 90674 | 182 | 149 | $50K | |
| G0008 | Administration of influenza virus vaccine | 223 | 181 | $28K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 577 | 257 | $27K |
| 82947 | 27 | 24 | $3K | |
| 90662 | 17 | 12 | $3K |